Incannex Healthcare (IXHL) Capital Expenditures (2023 - 2026)

Incannex Healthcare (IXHL) has reported Capital Expenditures for 4 consecutive years, with $5000.0 the latest figure, recorded in Q1 2026.

• Quarterly Capital Expenditures changed N/A year-over-year to $5000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $11000.0 (down 80.36% YoY) and the FY2025 annual result came in at $8000.0, down 97.11% from the prior year.
• Capital Expenditures improved to $5000.0 in Q1 2026 per IXHL's latest filing, from $4000.0 in the prior quarter.
• Over the last five years, Capital Expenditures for IXHL reached as high as $221000.0 in Q3 2023 and fell as low as -$6000.0 in Q1 2024.
• A 4-year average of $54555.6 and a median of $5000.0 in 2026 frame the typical range for Capital Expenditures.
• The largest YoY upside for Capital Expenditures was 98.25% in 2024 against a maximum downside of 118.75% in 2024.
• Year by year, Capital Expenditures stood at $59000.0 in 2023, then sank by 94.92% to $3000.0 in 2024, then jumped by 33.33% to $4000.0 in 2025, then rose by 25.0% to $5000.0 in 2026.
• According to Business Quant data, Capital Expenditures over the past three periods registered $5000.0, $4000.0, and $2000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.